IL-17 antagonist antibodies
US9676847B2 · kind B2 · utility
0Cited by
1References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2013 |
| Grant date | Jun 13, 2017 |
| Priority date | — |
| Expiry date | Jun 25, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/09
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to antibodies against human IL-17 which act as antagonists of IL-17, and their use in the diagnosis or treatment of IL-17 mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.